COVID-19 and toxicity from potential treatments: Panacea or poison
No Preview Available
Associated Records
Authors
File Licence
Editors
Date
2020-08-01
Source Title
EMA - Emergency Medicine Australasia
Journal Title
Journal ISSN
Volume Title
Publisher
WILEY
Melbourne Authors
Affiliation
Medical Education
Document Type
Journal Article
Subject Code
Citation
Wong, A. (2020). COVID-19 and toxicity from potential treatments: Panacea or poison. EMA Emergency Medicine Australasia, 32 (4), pp.697-699. https://doi.org/10.1111/1742-6723.13537.
Access Status
Access this item via the Open Access location
Access URL
Open Access URL
Open Access at PMC
Linked Resource URL
NHMRC Grant Code
ARC Grant Code
Description
Abstract
Since December 2019, coronavirus disease (COVID-19) has been increasingly spreading from its origin in Wuhan, China to many countries around the world eventuating in morbidity and mortality affecting millions of people. This pandemic has proven to be a challenge given that there is no immediate cure, no vaccine is currently available and medications or treatments being used are still undergoing clinical trials. There have already been examples of self-medication and overdose. Clearly, there is a need to further define the efficacy of treatments used in the management of COVID-19. This evidence needs to be backed by large randomised-controlled clinical trials. In the meantime, there will no doubt be further off-label use of these medications by patients and practitioners and possibly related toxicity.